参考文献/References:
［1］Joham A E. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome:data from the Australian longitudinal study on women's health ［J］. Human Reproduction, 2014, 29 (4): 802-808.
［2］Bulletins——Gynecology ACOP. ACOG Practice Bulletin No. 108: Polycystic ovary syndrome ［J］. Obstetrics & Gynecology, 2009, 114 (4):936-949.
［3］Acog Practice Bulletin No. 194 Summary:Polycystic Ovary Syndrome［J］.Obstetrics & Gynecology,2018,131 (6):1174-1176.
［4］Nader S, E Diamanti-Kandarakis P O. Oral contraceptives and metabolic issues:new perspectives and a unifying hypothesis ［J］. Human Reproduction, 2007, 22 (2): 317-322.
［5］Dokras A. Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits ［J］. Fertility and Sterility, 2016, 106 (7): 1572-1579.
［6］Legro R S, Arslanian S A, Ehrmann D A, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline ［J］. The Journal of Clinical Endocrinology and Metabolism, 2013, 98 (12): 4565-4592.
［7］Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group ［J］. Fertility and Sterility, 2012, 97 (1): 28-38.e 25.
［8］Archer J S, Chang R-J. Hirsutism and acne in polycystic ovary syndrome ［J］. Best Practice & Research. Clinical Obstetrics & Gynaecology, 2004, 18 (5): 737-754.
［9］Vrbikova J, Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome ［J］. Human Reproduction Update, 2005, 11 (3): 277-291.
［10］Yildiz B O. Approach to the patient: contraception in women with polycystic ovary syndrome ［J］. Journal of Clinical Endocrinology & Metabolism, 2015, 100 (3): 794-802.
［11］Navaratnarajah R C, Hardiman P. Polycystic ovary syndrome and endometrial cancer ［J］. Seminars in Reproductive Medicine, 2008, 26 (1): 62-71.
［12］Haoula Z S, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome ［J］. Human Reproduction, 2012, 27 (5): 1327-1331.
［13］Barry J A, P J Hardiman R O. Ovarian and breast cancer in women with polycystic ovary syndrome:a systematic review and meta-analysis ［J］. Human Reproduction Update, 2014, 20 (5): 748-758.
［14］Dokras A, Clifton S, Futterweit W, et al. Increased risk for abnormal depression scores in women with polycystic ovary syndrome a systematic review and Meta-Analysis ［J］. Obstetrics and Gynecology, 2011, 117 (1): 145-152.
［15］Dokras A, Clifton S, Futterweit W, et al. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis ［J］. Fertility and Sterility, 2012, 97 (1): 225-230.
［16］Thomson R L, Buckley J D, LIM S S, et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome ［J］. Fertility and Sterility, 2010, 94 (5): 1812-1816.
［17］Dokras A. Weight loss and lowering androgens predict improvements in Health-Related quality of Life in women with PCOS ［J］. The Journal of Clinical Endocrinology and Metabolism, 2016, 101 (8): 2966-2974.
［18］Cinar N. Effect of an oral contraceptive on emotional distress,anxiety and depression of women with polycystic ovary syndrome:a prospective study ［J］. Human Reproduction, 2012, 27 (6): 1840-1845.
［19］Chasan-taber C L. A prospective study of oral contraceptives and NIDDM among U ［J］. S.women.Diabetes Care, 1997, 20 (3): 330-335.
［20］De Bastos M, Stegeman B H, Rosendaal F R, et al. Combined oral contraceptives: venous thrombosis ［J］. Cochrane Database of Systematic Reviews, 2014 (3): Cd 010813.
［21］Okoroh, M E. Is polycystic ovary syndrome another risk factor for venous thromboembolism United States ［J］. American Journal of Obstetrics and Gynecology, 2012, 207 (377): e 1-e 8.
［22］Bird S T, Hartzema A G, Brophy J M, et al. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis ［J］.Canadian Medical Association Journal, 2013, 185 (2): E 115-E 120.
［23］WEI Daimin, SHI Yuhua, LI Jing, et al. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome ［J］. Human Reproduction 2017, 32 (2): 354-361.
相似文献/References:
[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.